| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Airway Obstruction | D000402 | 13 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hearing Loss, Sensorineural | D006319 | 8 associated lipids |
| Otitis Media | D010033 | 12 associated lipids |
| Carcinoma, Basal Cell | D002280 | 6 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| pmid:21439162 | ||||
| Zhou QT et al. | How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder? | 2016 | AAPS J | pmid:27255350 |
| Gandhi SV et al. | Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs. | 2014 | AAPS PharmSciTech | pmid:24557773 |
| Shunmugaperumal T and Kaur V | In Vitro Anti-inflammatory and Antimicrobial Activities of Azithromycin After Loaded in Chitosan- and Tween 20-Based Oil-in-Water Macroemulsion for Acne Management. | 2016 | AAPS PharmSciTech | pmid:26314246 |
| Wei W et al. | MPEG-PCL Copolymeric Micelles for Encapsulation of Azithromycin. | 2018 | AAPS PharmSciTech | pmid:29675667 |
| Wendel TD | 1-day azithromycin was as effective as 7-day doxycycline for nongonococcal urethritis syndrome in men. | 1996 Nov-Dec | ACP J. Club | pmid:8912627 |
| Russo V et al. | Azithromycin-induced QT prolongation in elderly patient. | 2006 | Acta Biomed | pmid:16856707 |
| Delmée M et al. | In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin. | 1996 | Acta Clin Belg | pmid:8858889 |
| Moi H et al. | Spontaneous Regression of Untreatable Mycoplasma genitalium Urethritis. | 2015 | Acta Derm. Venereol. | pmid:25634824 |
| Cusini M | Therapy for Gonococcal and Non-gonococcal Genital Infections is a Major Problem for Clinicians. | 2015 | Acta Derm. Venereol. | pmid:25917593 |
| Unemo M et al. | Five-day Azithromycin Treatment Regimen for Mycoplasma genitalium Infection Also Effectively Eradicates Chlamydia trachomatis. | 2015 | Acta Derm. Venereol. | pmid:25823977 |
| Brkljacić N et al. | Stevens-Johnson syndrome as an unusual adverse effect of azithromycin. | 2006 | Acta Dermatovenerol Croat | pmid:16603101 |
| Basta-Juzbasić A et al. | A dose-finding study of azithromycin in the treatment of acne vulgaris. | 2007 | Acta Dermatovenerol Croat | pmid:17868539 |
| Innocenzi D et al. | Moderate acne vulgaris: efficacy, tolerance and compliance of oral azithromycin thrice weekly for. | 2008 | Acta Dermatovenerol Croat | pmid:18358103 |
| Vcev A et al. | Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease. | 1998 | Acta Med Croatica | pmid:9988898 |
| Vladusić I et al. | [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review]. | 2006 | Acta Med Croatica | pmid:16933840 |
| Dzelalija B et al. | Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. | 2002 | Acta Med Croatica | pmid:12596623 |
| Hincapié JP et al. | Microbiological effects of periodontal therapy plus azithromycin in patients with diabetes: results from a randomized clinical trial. | 2014 | Acta Odontol Latinoam | pmid:25523961 |
| Wirostko BM and Wirostko WJ | The possible role of systemic azithromycin for idiopathic iridocyclitis. | 2010 | Acta Ophthalmol | pmid:19891670 |
| Lacroix JS et al. | Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. | 2002 | Acta Otolaryngol. | pmid:11936912 |
| Edvinsson M et al. | Chlamydophila pneumoniae in chronic rhinosinusitis. | 2006 | Acta Otolaryngol. | pmid:16864493 |
| Safak MA et al. | A comparative study of azithromycin and pseudoephedrine hydrochloride for otitis media with effusion in children. | 2001 | Acta Otolaryngol. | pmid:11813896 |
| Otake H et al. | Antimicrobial prophylaxis in tonsillectomy: the efficacy of preoperative single-dose oral administration of azithromycin in preventing surgical site infection. | 2014 | Acta Otolaryngol. | pmid:24215215 |
| GarcÃa Callejo FJ et al. | [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections]. | 1998 | Acta Otorrinolaringol Esp | pmid:9707742 |
| Bhattacharya MK et al. | Azithromycin in the treatment of cholera in children. | 2003 | Acta Paediatr. | pmid:12856976 |
| Coulter JB et al. | Nontuberculous mycobacterial adenitis: effectiveness of chemotherapy following incomplete excision. | 2006 | Acta Paediatr. | pmid:16449024 |
| Wasnik S et al. | Preparation and characterization of floating drug delivery system of azithromycin. | 2012 May-Jun | Acta Pol Pharm | pmid:22594266 |
| Schémann JF et al. | Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali. | 2007 | Acta Trop. | pmid:17239332 |
| Noedl H et al. | Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. | 2001 | Acta Trop. | pmid:11495642 |
| DeÄŸerli K et al. | Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. | 2003 | Acta Trop. | pmid:12943976 |
| Nakornchai S and Konthiang P | Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. | 2006 | Acta Trop. | pmid:17126280 |
| MartÃn JM et al. | Azithromycin for the Treatment of Ciclosporin-Induced Gingival Hyperplasia. | 2016 | Actas Dermosifiliogr | pmid:26996332 |
| Mathew A et al. | Antimicrobial and Immunomodulatory Surface-Functionalized Electrospun Membranes for Bone Regeneration. | 2017 | Adv Healthc Mater | pmid:28240815 |
| Snapp B and Fischetti D | Bordetella pertussis infection in infants: a reemerging disease. | 2013 | Adv Neonatal Care | pmid:23532029 |
| Woolard S and Kenkel D | Heading off antibiotic resistance. | 2001 | Adv Nurse Pract | pmid:12420432 |
| Rodriguez WJ and Wiedermann BL | The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. | 1994 | Adv Pediatr Infect Dis | pmid:8123221 |
| Dorfman MS et al. | The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment. | 2008 | Adv Ther | pmid:18369536 |
| Luchs J | Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. | 2008 | Adv Ther | pmid:18781287 |
| Gambhir M et al. | Modelling trachoma for control programmes. | 2010 | Adv. Exp. Med. Biol. | pmid:20632535 |
| Siekmeier R et al. | Inhalation of macrolides: a novel approach to treatment of pulmonary infections. | 2015 | Adv. Exp. Med. Biol. | pmid:25252902 |
| Mabey D | Trachoma: recent developments. | 2008 | Adv. Exp. Med. Biol. | pmid:18193660 |
| Kyebambe P | Incomplete Reiter's arthritis in a 23 year old nursing mother. | 2004 | Afr Health Sci | pmid:15687073 |
| Ives DV et al. | Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. | 1995 | AIDS | pmid:7755914 |
| Nasta P and Chiodera S | Azithromycin for relapsing cerebral toxoplasmosis in AIDS. | 1997 | AIDS | pmid:9233470 |
| Hirbod T et al. | HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. | 2008 | AIDS | pmid:18356602 |
| Steven N et al. | Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection. | 1994 | AIDS | pmid:8011231 |
| Wawer MJ et al. | A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. | 1998 | AIDS | pmid:9677171 |
| Bayoumi AM and Redelmeier DA | Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. | 1998 | AIDS | pmid:9727572 |
| Moyle GJ et al. | Once weekly azithromycin as prophylaxis against recurrence of non-tuberculous mycobacterial infections in HIV-1-positive individuals. | 1998 | AIDS | pmid:9727581 |